These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 117214)
1. [Progress in cancer treatment with drugs]. Krankenpfl Soins Infirm; 1979; 72(11):441-3. PubMed ID: 117214 [No Abstract] [Full Text] [Related]
2. Targeted agents: the rules of combination. Kwak EL; Clark JW; Chabner B Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749 [TBL] [Abstract][Full Text] [Related]
3. Food and Drug Administration requirements for approval of new anticancer drugs. Johnson JR; Temple R Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094 [TBL] [Abstract][Full Text] [Related]
4. Fast track for AIDS and cancer drugs. Gershon D Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690 [No Abstract] [Full Text] [Related]
5. Cancer drugs. Weighing the risks and benefits. Bren L FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832 [TBL] [Abstract][Full Text] [Related]
6. Panel recommends changes to expedite approval of cancer, AIDS drugs. Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248 [No Abstract] [Full Text] [Related]
7. Unproven methods of cancer treatment: H.11. CA Cancer J Clin; 1970; 20(3):172-5. PubMed ID: 4988623 [No Abstract] [Full Text] [Related]
8. Cancer drug approval in the United States, Europe, and Japan. Milsted RA Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686 [No Abstract] [Full Text] [Related]
9. Sharks do get cancer: few surprises in cartilage research. Finkelstein JB J Natl Cancer Inst; 2005 Nov; 97(21):1562-3. PubMed ID: 16264172 [No Abstract] [Full Text] [Related]
10. [Current progress in cancer therapy]. Domellöf L Lakartidningen; 1977 Jan; 74(1-2):22-3. PubMed ID: 831023 [No Abstract] [Full Text] [Related]
11. Planning combined therapy--the interaction of experimental and clinical studies. Carter SK Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498 [No Abstract] [Full Text] [Related]
12. New initiatives aim to test more cancer drugs for children. Brower V J Natl Cancer Inst; 2004 Dec; 96(24):1808-10. PubMed ID: 15601634 [No Abstract] [Full Text] [Related]
13. Targeting tumors. Sobel RK US News World Rep; 2000 Oct; 129(13):48-50. PubMed ID: 11183328 [No Abstract] [Full Text] [Related]
14. The investigational new drug application--who benefits? Freireich EJ Nat Clin Pract Oncol; 2006 Feb; 3(2):62-3. PubMed ID: 16462826 [No Abstract] [Full Text] [Related]
15. Solid tumor chemotherapy: new drugs and horizons. Yardumian H J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203 [No Abstract] [Full Text] [Related]
16. Can single-patient investigational new drug studies hurry slow trains to the fast track? Chenoweth D Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594 [TBL] [Abstract][Full Text] [Related]
17. Swimming upstream: an advocate reflects on cancer research and social realities. Mayer M J Clin Oncol; 2008 Jun; 26(16):2783-6. PubMed ID: 18509190 [No Abstract] [Full Text] [Related]
18. Developing drugs that do not cause tumor regression. Stadler W Clin Adv Hematol Oncol; 2003 Nov; 1(11):654-5. PubMed ID: 16258462 [No Abstract] [Full Text] [Related]
19. Black, white, or shades of gray? Glatstein E Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1307. PubMed ID: 19028272 [No Abstract] [Full Text] [Related]
20. Reimbursement for cancer treatment: coverage of off-label drug indications. American Society of Clinical Oncology J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]